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Tooth development is initiated by signals from the oral ectoderm which induce gene expression required for tooth
development in the underlying mesenchyme. In this study, we have used Su5402, an inhibitor of FGF receptor signaling, to
analyze the requirement of FGF signaling during early tooth development. We show that FGF signaling is necessary for
expression of Pax9, a transcription factor required for development of all teeth, in prospective incisor and molar
mesenchyme until E11.0. Expression of the LIM homeobox gene Lhx7 also requires FGF signaling until E11.0 whereas
expression of its homologue Lhx6 and the homeobox transcription factor Barx1 already becomes independent of FGF
signaling at E10.75. In contrast, ectodermal expression of several genes thought to be important for tooth development was
unaffected by the block of FGF signaling. Finally, we show that expression of the TGFb antagonist Dan in prospective tooth
mesenchyme requires ectodermal signals and can be induced by FGF-soaked beads but is maintained in mandibular explants
in the absence of FGF signaling. Together, these results demonstrate that FGF signaling is required for development of both
molar and incisor teeth and suggest that specification of tooth mesenchyme involves at least two FGF-dependent
steps. © 2001 Elsevier Science
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Vertebrate organs typically develop from epithelial and
mesenchymal tissues. Signaling between these two tissues
regulates many aspects of organ development, from the
initiation of organogenesis to terminal differentiation of
specific cell types (Grobstein, 1967; Thesleff et al., 1995).
One of the classical model systems to study such
epithelial–mesenchymal interactions and the underlying
molecular mechanisms is the murine tooth. The first mor-
phological sign of tooth development is a local thickening
of the stomodeal ectoderm in the prospective tooth-forming
regions at E11.5 of mouse development. This thickened
ectoderm then invaginates into the underlying mesen-
chyme and stimulates mesenchymal proliferation and con-
densation around the epithelial bud (E12–E13). During the
following stages of development (E13.5–E16.5), tooth type-
specific shape is established followed by terminal differen-
tiation of dentine-secreting odontoblasts from tooth mes-
enchyme and enamel-secreting ameloblasts from dental
epithelium.
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548Tissue recombination experiments have revealed that all
stages of tooth development are regulated through sequen-
tial interactions between the oral ectoderm and the under-
lying neural crest-derived mesenchyme (Thesleff and Hur-
merinta, 1981). Before E12.5, the oral ectoderm is able to
induce tooth development in neural crest-derived mesen-
chyme that does not normally form teeth. After E12.5, this
potential shifts to the mesenchyme, which then acquires
the ability to instruct nondental ectoderm to form tooth-
specific structures (Lumsden, 1988; Mina and Kollar, 1987).
These data indicate that the ectoderm is the source of
signals, which instruct the underlying mesenchyme to form
teeth, and that the mesenchyme itself is not specified to
form teeth until E12.5.
Recently, some of the signaling molecules regulating the
initiation and subsequent stages of tooth development have
been identified. Among these are members of the fibroblast
growth factor (FGF) and bone morphogenetic protein (BMP)
families which act as morphogenetic signals mediating
tissue interactions at various stages of tooth development
(Jernvall and Thesleff, 2000; Peters and Balling, 1999). Fgf8
is expressed in the ectoderm covering the tooth-forming
region at the initiation stage. Recombinant FGF8 protein
can substitute for the oral ectoderm to induce the expres-
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549FGF Signaling during Early Tooth Developmentsion of the transcription factors Pax9, Barx1, Lhx6, Lhx7,
and Pitx1 in prospective tooth mesenchyme at E10.5 in
vitro (Grigoriou et al., 1998; Neubuser et al., 1997; St.
Amand et al., 2000; Tucker et al., 1998b). The induction of
Pax9, which is required for tooth development to proceed
beyond the bud stage, is restricted to the sites of prospective
tooth development through repression by BMP4 and BMP2.
Therefore, antagonistic interactions between FGF and BMP
signaling might be involved in specifying the sites of tooth
development (Neubuser et al., 1997; Peters et al., 1998).
Besides Fgf8, other members of the FGF family, Fgf3, Fgf4,
Fgf9, and Fgf10, are also expressed at different stages of
odontogenesis (Kettunen et al., 2000; Kettunen and
Thesleff, 1998). Fgf9 is coexpressed with Fgf8 in the oral
ectoderm at the initiation stage, Fgf3 and -10 are expressed
in the dental mesenchyme at later stages, and Fgf3, -4, and
-9 are also expressed in the enamel knot, a signaling center
within the dental ectoderm which is thought to control
tooth shape.
Inactivation of Fgf8 in the ectoderm covering the first
branchial arch (ba1) through conditional gene targeting
resulted in a significant increase in the amount of cell death
in proximal ba1 mesenchyme at E9.0 (Trumpp et al., 1999).
At birth, these mutant embryos lacked molar teeth and
most ba1-derived structures, but incisors and structures
derived from the distalmost region were still present. In
spite of this severe phenotype, expression of several mark-
ers previously identified as FGF-dependent genes in vitro
was surprisingly normal at earlier stages. This phenotype
clearly demonstrates that Fgf8 is required for normal ba1
morphogenesis and for molar tooth development, but it also
leaves a number of open questions: Is, as suggested by the
authors, the relative normal development of distal ba1
structures and incisors and the maintenance of the expres-
sion of some suggested FGF8-dependent genes the conse-
quence of the presence of other members of the FGF family?
Or are FGFs only minor players during incisor tooth devel-
opment and in the regulation of the expression of these
genes? Is the lack of molar teeth a consequence of the large
amount of cell death observed at E9.0, or is FGF8 required
as an inductive signal at the initiation stage of tooth
development? What is the precise stage dependency of the
requirement for FGF signaling for individual genes regu-
lated by FGF signaling during early tooth development?
To address these questions we have blocked FGF signal-
ing in mandibular explants in vitro at the initiation stage of
tooth development (E10–E11) by using Su5402, an oxoin-
dole derivative that specifically binds to the nucleotide
binding site of FGF receptors and inhibits signaling. Su5402
has previously been used successfully to study the function
of FGF signaling in a variety of developmental processes
(Mohammadi et al., 1997; Muhr et al., 1999; Norlin et al.,
2000; Picker et al., 1999; Rodriguez Esteban et al., 1999;
Schneider et al., 1999; Wilson et al., 2000). This approach
avoided the problem of redundancy between different mem-
bers of the FGF family and allowed us to investigate the role
of FGF signaling during early tooth development in the
© 2001 Elsevier Science. Acontext of an intact ba1, circumventing the requirement of
FGF signaling for cell survival at E9.0. Furthermore, it
enabled us to study the stage dependence of the require-
ment for FGF signaling. Our results demonstrate that FGF
signaling is required for the development of both molar and
incisor teeth and that initiation of tooth development and
specification of the dental mesenchyme involves at least
two FGF-dependent events. Our results furthermore show
that FGF signaling is not required for the expression of Fgf8
and several other signaling molecules and the homeobox
gene Pitx2 in the oral ectoderm between E10 and E11.
MATERIALS AND METHODS
Explant Culture, Tissue Recombination,
and Bead Implantation
Embryos were collected from matings of FVBN mice. Noon of
the day on which the vaginal plug was detected was considered as
day E0.5 of development, but embryos were staged more precisely
by counting somite numbers upon dissection as described by
Kaufman (1994) (E10.25 5 27–31 somites (S), E10.5 5 32–36S,
E10.75 5 37–40S, and E11.0 5 41–44S). Mandibular explants were
isolated and cultured as previously described (Neubuser et al.,
1997).
Separation of ectoderm and mesenchyme, tissue recombinations
and bead implantations were performed according to published
protocols (Vainio et al., 1993; Neubu¨ser et al., 1997). Heparin-
coated acrylic beads (Sigma) were soaked in recombinant human
FGF4, mouse FGF8b, or human FGF9 protein (1 mg/ml; R&D
Systems) or PBS for 1 h at 37°C. Q2bn cells expressing human
BMP2 were cultured as previously published (Duprez et al., 1996).
Spherical cell aggregates for the implantation into mandibular
explants were prepared by plating the cells at high density on
bacterial petri dishes for 24 h. Beads or cell aggregates were placed
on mandibular mesenchyme for 24 h and explants were then
processed for RNA in situ hybridization.
For analysis of the effects of Su5402 (Calbiochem; .95% purity),
explants were cultured in medium containing 25 mM Su5402 and
0.5% DMSO, or 0.5% DMSO alone. Gene expression patterns of all
genes described in this study were analyzed after 4 and 24 h of
culture in the presence of Su5402. Only explants fixed after 4 h are
shown unless otherwise indicated.
For the study of long-term effects of Su5402, explants were
cultured in the presence of 25 mM Su5402, 0.5% DMSO, or DMSO
alone for 24 h, followed by 24 h of culture in normal culture
medium. The explants were either fixed immediately and pro-
cessed for RNA in situ hybridization or were transplanted under
the kidney capsule of adult mice to allow for full tooth develop-
ment. Ten days after transplantation, the mice were sacrificed and
the teeth that had developed from the transplants were dissected
from the surrounding alveolar bone and assayed for their morpho-
logical appearance.
RNA in Situ Hybridization
For whole-mount RNA in situ hybridization, mandibular ex-
plants were fixed, processed, and hybridized according to the
protocol described by Henrique et al. (1995). Digoxigenin-labeled
antisense riboprobes were detected with alkaline phosphatase-
ll rights reserved.
550 Mandler and Neubu¨serFIG. 1. FGF signaling is required for the expression of Pax9 in prospective molar and incisor mesenchyme. Pax9 RNA in situ hybridization
of E10.5, E10.75, and E11.0 mandibular explants cultured in the presence of various concentrations of Su5402 (A–H). Explants were cultured
for 24 (A–D) or 4 h (E–H) in DMEM without (control) or with the indicated amount of Su5402. Expression of Fgf8 and Fgf9 in mandibular
ectoderm at E10.5 and E11.5 (I, K). Expression of Pax9 in E10.5 mandibular mesenchyme cultured in contact with PBS (1), FGF8 (asterisks),
or FGF9 (filled circles) soaked beads (J, L). “m” and “i” label Pax9 expression in presumptive molar and incisor mesenchyme.
FIG. 2. Inhibition of FGF signaling is fully reversible. Expression of Pax9 is reinduced in explants first cultured for 24 h in the presence
of 25 mM Su5402 followed by 24 h of culture in the absence of the inhibitor and it resembles the expression in explants cultured for 48 h
in DMEM (A, B). When transplanted under the kidney capsule for 10 days, explants treated with Su5402 formed normal molar teeth that
were indistinguishable from the molars that developed from explants not treated with Su5402 (C, D). “m” and “i” indicate prospective
molar and incisor regions, and “*” indicates cusps of the developing molars.
© 2001 Elsevier Science. All rights reserved.
551FGF Signaling during Early Tooth DevelopmentFIG. 3. FGF signaling is required for the expression of Lhx7, Lhx6, and Barx1 in a stage-dependent manner. Mandibular explants were
isolated at different stages of development and cultured in the presence or absence of 25 mM Su5402. Lhx7 expression is lost in the presence
of Su5402 at E10.5 and E10.75 but is not affected at E11.0, when its expression becomes independent of ectodermal FGF signals (A–F). Lhx6
and Barx1 expression is lost from ba1 explants in the presence of Su5402 at E10.5 but becomes independent of FGF signaling at E10.75 (G–J
and K–N, respectively). Expression analysis on serial sections of an E10.5 explant treated with Su5402 confirmed that Pax9 and Lhx7 still
require FGF signaling at that stage, whereas Lhx6 and Barx1 has already become independent (O–R).
552 Mandler and Neubu¨sercoupled anti-digoxigenin antibodies using BM purple as the color
substrate (all reagents were obtained from Roche Molecular Bio-
chemicals). For RNA in situ hybridization on paraffin sections (6
mm), embryos were processed, sectioned, and hybridized with
digoxigenin-labeled riboprobes as described by Neubuser et al.
(1995) with some modifications. A detailed protocol is available
upon request.
The plasmids used to prepare the antisense riboprobes presented in
this study have previously been described: Pax9 (Neubuser et al.,
1995), Fgf8 (Crossley and Martin, 1995), Fgf9 (Colvin et al., 1999),
Lhx6 and Lhx7 (Grigoriou et al., 1998), Pitx1 (Lanctot et al., 1997),
Pitx2 (Campione et al., 1999), Msx1 (MacKenzie et al., 1991), Msx2
(Monaghan et al., 1991), Shh (Echelard et al., 1993), Bmp4 (Wozney et
al., 1988), and Dan (Stanley et al., 1998). Barx1 was cloned from E10.5
mouse c-DNA by PCR amplification using the following primers:
(59-AAGCTGGAAGCAGCTGG-39 and 59-CAGGTATCAGCTGA-
TCTGC-39). The resulting PCR product was cloned by using the
TopoTA cloning vector (Invitrogen) and sequenced. Explants were
photographed in PBT under a Leica MZ Apo microscope by using a
Sony 3CCD digital camera.
RESULTS
FGF Signaling Is Required for the Expression
of Pax9 in Prospective Incisor and Molar
Mesenchyme at the Initiation Stage
of Tooth Development
The paired box transcription factor Pax9 is normally
expressed in two domains within ba1 mesenchyme fore-
shadowing the prospective molar and incisor fields at E10.5
and is required for the development of all teeth (Neubu¨ser
et al., 1997; Peters et al., 1998). In mouse embryos lacking
Fgf8 function in ba1 ectoderm, expression of Pax9 in the
molar region was lost but expression in the prospective
incisor region was maintained (Trumpp et al., 1999).
In order to test whether Pax9 expression in both molar
and incisor mesenchyme requires FGF signaling at the
initiation stage of tooth development, we cultured E10.5
mandibular explants consisting of ectoderm and mesen-
chyme in the presence of the FGFR antagonist Su5402.
Culture of explants in the presence of 5 mM Su5402 for 24 h
resulted in the loss of the incisor domain and downregula-
tion of Pax9 expression in the prospective molar region (Fig.
1B, n 5 5/5 compare to Fig. 1A, n 5 14/14). Treatment with
15 or 25 mM Su5402 for 24 h resulted in complete loss of
Pax9 expression (Figs. 1C, n 5 5/5, and 1D, n 5 17/17). Loss
of Pax9 expression was already observed within 4 h of
culture in the presence of 25 mM Su5402 (Fig. 1E, n 5 5/5).
In contrast, culture of explants in the presence of inhibitors
of the EGFR or PDGFR had no effect on expression of Pax9
(data not shown). These results demonstrate that Pax9
expression in both molar and incisor mesenchyme requires
FGF signaling at E10.5.
It has previously been shown that expression of Pax9
becomes independent of ectodermal signals later in tooth
development (Neubuser et al., 1997). In order to determine
at which stage Pax9 expression becomes independent of
FGF signaling, we examined the effect of Su5402 treatment
© 2001 Elsevier Science. Aon Pax9 expression at different stages of early tooth devel-
opment. As at E10.25 (data not shown) and E10.5, expres-
sion of Pax9 was completely lost in E10.75 explants cul-
tured for 4 or 24 h in the presence of Su5402 (Fig. 1F, n 5 8/8
and data not shown), but was maintained in E11.0 explants,
albeit at a reduced level in the incisor region (Fig. 1H, n 5
5/5 compare to Fig. 1G, n 5 5/5). This indicated that Pax9
expression remains dependent on FGF signaling through
E10.75 but starts to become independent of FGF around
E11.0.
Trumpp et al. (1999) demonstrated that Pax9 is still
expressed in the prospective incisor mesenchyme of mouse
embryos in the absence of Fgf8 function. Together with our
results, this suggests that another member of the FGF
family might regulate Pax9 expression in that region. Fgf9
is expressed in the oral ectoderm at the initiation stage of
tooth development and its expression domain overlaps with
that of Fgf8 but extends further distally into the ectoderm
covering prospective incisor mesenchyme (Figs. 1I and 1K;
Kettunen and Thesleff, 1998). Furthermore, Fgf9 expression
is maintained in Fgf8-deficient embryos (Trumpp et al.,
1999). We therefore examined whether FGF9 protein would
be sufficient to stimulate Pax9 expression in mandibular
mesenchyme. For this purpose, we cultured E10.5 mandib-
ular mesenchyme in contact with beads soaked in FGF8,
FGF9, or PBS. After 24 h, Pax9 was expressed at high levels
in explants cultured with FGF8 or FGF9 but no expression
was detectable in explants cultured with PBS beads (Figs. 1J
and 1L, n 5 3/3 each). This clearly shows that FGF9, similar
to FGF8, can substitute for the ectoderm to stimulate Pax9
expression.
Finally, we examined whether inhibition of FGF signal-
ing by Su5402 leads to a reversible or irreversible block in
tooth development. For this purpose, mandibular explants
of E10.5 mouse embryos were first cultured for 24 h in the
presence of 25 mM Su5402 followed by an additional 24 h of
culture in the absence of the inhibitor. These explants were
then fixed and further analyzed for Pax9 expression. In
control explants that had been cultured for 48 h in the
absence of Su5402, two discrete Pax9 expression domains
foreshadowing the presumptive molar and incisor region
were detectable (Fig. 2A, n 5 6/6). In Su5402-treated ex-
plants that had been allowed to recover in the absence of
the inhibitor, these two domains were also present, even
though the overall expression was weaker than in controls
(Fig. 2B, n 5 7/7). In order to determine whether Su5402-
treated explants could form teeth, we transplanted them
under the kidney capsule of adult mice. Ten days after
transplantation, normal-looking teeth surrounded by alveo-
lar bone had developed from both Su5402-treated and con-
trol explants (Figs. 2C, n 5 3/3, and 2D, n 5 4/4; and data
not shown). No significant difference in appearance or size
was detected between teeth that had developed from con-
trol and Su5402-treated explants. In both cases, the teeth
showed a multicusps pattern typical for molars which was
confirmed by dissection of the dental epithelium and mes-
enchyme (data not shown). These results clearly show that
ll rights reserved.
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tooth development is fully reversible and that Su5402 does
not damage ba1 tissue in vitro.
The Effect of Su5402 on the Expression of Genes
Implicated as Target Genes of FGF Signaling
during Early Tooth Development
Studies using explant culture systems have implicated a
variety of mesenchymally expressed genes (e.g., Lhx6, Lhx7,
Barx1, and Pitx1) as target genes of FGF signaling during
early tooth development (Grigoriou et al., 1998; St. Amand
et al., 2000; Tucker et al., 1998b). Application of beads
soaked in recombinant FGF protein to explanted mesen-
chyme demonstrated that FGF signaling is sufficient for
expression of these genes. To test whether FGF signaling is
necessary for their expression, we examined the effect of
Su5402 on the expression of these genes. Expression of the
LIM homeobox transcription factors Lhx6 and Lhx7 is
normally detected in one domain in the proximal region of
ba1 at E10.25–E11.0 (Grigoriou et al., 1998, and Figs.
3A–3C). Between E10.25 and E10.75, treatment of mandib-
ular explants with 25 mM Su5402 (4 or 24 h) resulted in the
complete loss of expression of Lhx7 (Figs. 3D, n 5 13/13,
and 3E, n 5 10/11; and data not shown). In contrast, in
E11.0 explants, expression of Lhx7 was still present after
Su5402 treatment, indicating that Lhx7 expression is no
longer dependent on FGF signaling at that stage (Fig. 3F, n 5
4/4).
Expression of Lhx6 was also lost in the presence of
Su5402 in explants isolated from E10.25 and E10.5 em-
bryos, respectively (Figs. 3G and 3I, n 5 6/6; and data not
shown). In E10.75 explants, however, expression of Lhx6
was still detectable after culture in the presence of Su5402
(Figs. 3H and 3I, n 5 4/4), demonstrating that Lhx6 expres-
sion becomes independent of FGF signaling at an earlier
stage than Lhx7. This was unexpected because Lhx6 and -7
were previously reported to behave identically in tissue
recombination experiments (Grigoriou et al., 1998).
We next examined the effect of Su5402 on the expression
of Barx1, a transcription factor specifically expressed in the
presumptive molar region of ba1 (Mitsiadis et al., 1998;
Tissier-Seta et al., 1995). Barx1 expression was shown to be
regulated by FGF and BMP signaling in an antagonistic
manner in vitro and in vivo (Tucker et al., 1998b). In E10.25
and E10.5 explants treated with Su5402, expression of
Barx1 was undetectable in the proximal mesenchyme (Fig.
3M, n 5 10/12; and data not shown). In contrast, expression
of Barx1 was still detectable in Su5402-treated explants
isolated from E10.75 embryos (Fig. 3N, n 5 8/8), indicating
that Barx1 expression, as Lhx6, becomes independent of
FGF signaling around this time of development.
To exclude that the observed differences in the timing,
when Pax9, Lhx7, Lhx6, and Barx1 expression becomes
independent of FGF signaling, are due to staging errors, we
compared expression of these genes on serial sections of a
single E10.75 (38-somite stage) explant treated with
© 2001 Elsevier Science. ASu5402. This analysis confirmed that expression of Pax9
and Lhx7 still depends on FGF signaling at E10.75 (Figs. 3O
and 3P), whereas expression of Lhx6 and Barx1 is already
independent of FGF signaling at that stage (Figs. 3Q and 3R;
and data not shown).
Msx1 and Msx2 are homeobox transcription factors that
are expressed in the distal region of the early ba1 (MacKen-
zie et al., 1991, 1992). Both genes were shown to be
regulated by epithelial–mesenchymal interactions and to be
targets of BMP signaling in many regions of the embryo,
including ba1 (Barlow and Francis-West, 1997; Tucker et
al., 1998a; Vainio et al., 1993). In addition, FGF beads were
shown to be sufficient for the induction of Msx1 in ba1
mesenchyme at E12 (Kettunen and Thesleff, 1998). In E10.5
mandibular explants, no significant change in the expres-
sion of Msx1 and Msx2 was observed following Su5402
treatment, indicating that FGF signaling is not required for
the expression of these genes at that stage (Figs. 4E, n 5
10/10, and 4F, n 5 5/5).
Pitx1, a bicoid type homeobox gene, is normally ex-
pressed in oral epithelium and mesenchyme during early
ba1 development (Lanctot et al., 1997, 1999). Previous
experiments had shown that FGF protein is sufficient to
induce Pitx1 expression in ba1 ectoderm and mesenchyme
at E9.5. This expression can be repressed by the application
of BMP4 protein at E9.5 and E10.5 (St. Amand et al., 2000).
Interestingly, Su5402 treatment did not result in the loss of
Pitx1 expression in E10.5 ba1 explants in vitro (Fig. 4A, n 5
12/12). This clearly indicates that FGF signaling is not
necessary for the maintenance of Pitx1 expression in ba1
tissue at that stage.
Fgf8, Bmp4, Shh, and Pitx2 Expression in ba1
Ectoderm Is Maintained in the Absence of FGF
Signaling
Since only little is known about the function of FGF
signaling for patterning the early ba1 ectoderm, we exam-
ined the effect of blocking FGF signaling on the expression
of Fgf8, Bmp4, Shh, and Pitx2 in ba1 ectoderm. All four
genes have previously been shown to be essential for
normal tooth development (Dassule et al., 2000; Lin et al.,
1999; Lu et al., 1999; Sarkar et al., 2000; Trumpp et al.,
1999; Tucker et al., 1998b).
In E10.5 explants consisting of ectoderm and mesen-
chyme cultured in the presence of Su5402, Fgf8 expression
was maintained, indicating that Fgf8 expression in ba1
ectoderm is not regulated via a positive feedback loop (Figs.
5A and 5B, n 5 7/7). Bmp4 which is expressed in distal ba1
ectoderm in the embryo at E10.5 (Aberg et al., 1997) was
also still expressed in Su5402-treated explants (Figs. 5C and
5D, n 5 5/6). Similarly, expression of Shh, which is re-
stricted to prospective dental ectoderm at E10.5 (Dassule
and McMahon, 1998; Sarkar et al., 2000), was also not
altered in the presence of Su5402 (Figs. 5E and 5F, n 5 8/8).
Pitx2 has previously been shown to be expressed in odon-
togenic ectoderm but not in the underlying mesenchyme
ll rights reserved.
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554 Mandler and Neubu¨serthroughout development (Mitsiadis et al., 1998). As Pitx1,
it can be induced by FGF protein and inhibited by BMP
signaling (St. Amand et al., 2000). However, Pitx2 expres-
sion in Su5402-treated explants was not significantly al-
tered as compared to explants cultured in the absence of the
inhibitor (Figs. 5G and 5H, n 5 8/8). FGF signaling therefore
seems to be sufficient, but not necessary, for the expression
of both Pitx1 and -2 during early odontogenesis. Together,
these results suggest that FGF signaling might not be
crucial for patterning the early ba1 ectoderm.
FGF Signaling Is Sufficient but Not Necessary for
the Expression of Dan in ba1 Mesenchyme
One common mechanism to restrict the effects of signal-
ing molecules involves the induction of inhibitors of their
signaling pathway in adjacent tissues (Hirsinger et al., 1997;
Hsu et al., 1998; McMahon et al., 1998; Minowada et al.,
1999; Simpson et al., 1999). In ba1, Dan, the founding
member of the Dan family of TGFb antagonists, is ex-
pressed in the odontogenic mesenchyme at E10.5 and might
therefore be involved in restricting BMP signaling during
ongoing tooth development (Stanley et al., 1998). To test
whether Dan expression is regulated by ectodermal signals
and whether FGF or BMP signaling might be involved, we
cultured E10.5 mandibular mesenchyme in contact with
beads soaked in PBS or FGF, or with cell pellets secreting
BMP2. Dan expression in those explants was then com-
pared to expression in explants consisting of ectoderm and
mesenchyme.
In mesenchyme cultured without the ectoderm and in
contact with PBS beads, no expression of Dan was detect-
able after culture (Fig. 6C, n 5 6/6), whereas Dan expression
was maintained in explants consisting of ectoderm and
mesenchyme (Fig. 6B, n 5 10/10). Dan expression was also
FIG. 4. FGF signaling is not required for the expression of Pitx1,
mandibular explants with 25 mM Su5402 has no effect on the expdetectable in explants cultured in contact with beads
© 2001 Elsevier Science. Asoaked in FGF4 or FGF8 protein (Fig. 6D, n 5 12/12; and
data not shown) but not in mesenchyme cultured in contact
with cell pellets secreting BMP2 (Fig. 6E, n 5 7/7). Interest-
ingly, expression of Dan was only stimulated by FGF beads
in a rather narrow region in the medial part of the explant
(see Fig. 6D). In explants consisting of ectoderm and mes-
enchyme cultured in the presence of Su5402, Dan expres-
sion was unchanged as compared to explants cultured in the
absence of the inhibitor (Fig. 6F, n 5 12/12). Together, these
results demonstrate that Dan expression in ba1 mesen-
chyme is dependent on epithelial signals at E10.5 and that
FGF4/FGF8 but not BMP2 protein is sufficient for main-
taining expression in the absence of the ectoderm. FGF
signaling, however, seems not to be necessary for maintain-
ing Dan expression.
DISCUSSION
FGF Signaling Is Required for Molar and Incisor
Tooth Development
The paired box transcription factor Pax9 is required for
tooth development to proceed beyond the bud stage (Peters
et al., 1998). Throughout tooth development, Pax9 expres-
sion is restricted to the dental mesenchyme and it labels
prospective molar and incisor fields prior to any morpho-
logical manifestation of tooth development. Tissue recom-
bination experiments have demonstrated that Pax9 expres-
sion in both domains requires ectodermal signals at E10.5
and that FGF8, which is produced in the overlying ecto-
derm, is sufficient for the induction of Pax9 (Neubuser et
al., 1997). Whether Pax9 expression requires FGF signaling,
however, remained to be investigated. Mouse embryos in
which Fgf8 has been inactivated in the ectoderm covering
the first branchial arch have recently been described and
1, and Msx2 in mandibular explants at E10.5. Treatment of E10.5
n of Pitx1 (A, D), Msx1 (B, E), and Msx2 (C, F).Msxshow extensive cell death in the proximal ba1 mesenchyme
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555FGF Signaling during Early Tooth DevelopmentFIG. 5. Inhibition of FGF signaling has no effect on ectodermal expression of Fgf8, Bmp4, Shh, and Pitx2 in ba1 explants at E10.5.
Expression of all four genes is still detectable in explants cultured the presence of 25 mM Su5402 (A–H).
FIG. 6. Regulation of Dan expression at E10.5 of development. Dan is expressed in maxillary and mandibular mesenchyme and is upregulated
around the developing nasal placode (A). Expression of Dan is maintained in cultured mandibular explants consisting of ectoderm and
mesenchyme (B), but is lost in mesenchyme explants cultured without ectoderm (but with beads soaked in PBS) (C). Its expression can be
maintained by FGF-soaked beads (D) but not by BMP2-producing cells (E). Su5402 treatment, however, has no effect on Dan expression at E10.5,
indicating that FGF signaling is not necessary for maintaining Dan expression at that stage (F). np, nasal placode; mx, maxilla; mn, mandibula.
“1” labels PBS-soaked beads; “*” labels FGF4-soaked beads; and the dashed circle indicates the position of a pellet of BMP2-producing cells.
© 2001 Elsevier Science. All rights reserved.
556 Mandler and Neubu¨serat E9.0 (Trumpp et al., 1999). In such embryos, Pax9 was
not expressed in the prospective molar region at E10.5, and
no molar teeth were formed. Expression in the incisor
region, however, was maintained and incisor teeth were
present at birth. This phenotype raised two questions: First,
whether the loss of Pax9 in the molar region was due to the
loss of FGF8 as an inductive signal or a consequence of the
extensive cell death at E9.0, and second, whether expres-
sion in the incisor region was maintained by other members
of the FGF family or whether it did not require FGF
signaling at all. Our finding that both domains of Pax9
expression disappear in E10.5 mandibular explants cultured
in the presence of Su5402 clearly demonstrates that Pax9
expression in both regions requires FGF signaling at that
stage. Since Pax9 is essential for odontogenesis, develop-
ment of both tooth types depends on FGF as an inductive
signal. In the absence of FGF8, other members of the FGF
family must therefore maintain Pax9 expression in the
incisor mesenchyme. Fgf9 is expressed in the ectoderm on
the oral side of the mandibular arch at the initiation stage of
tooth development. Its expression extends further distally
into the region of prospective incisor development than
that of Fgf8. Furthermore, our results show that FGF9 is
sufficient to stimulate Pax9 expression in explanted man-
dibular mesenchyme. It is therefore very likely that FGF8
and FGF9 act together to control the expression of FGF
responsive genes, including Pax9, in early ba1 mesen-
chyme. The development of the distal most ba1 structures,
including the incisor teeth, but not of more proximal
structures in the absence of FGF8 would presumably be a
consequence of the spatially more restricted and more
distal expression of Fgf9. Fgf9-null mice have recently been
described, but no information on tooth development in
these mutants is yet available (Colvin et al., 2001a,b).
Therefore it remains to be examined whether Fgf9 is re-
quired for development of incisor teeth or whether incisor
tooth development is only blocked when both Fgf8 and Fgf9
are mutated.
The Su5402-mediated block of FGF signaling is fully
reversible. Removal of this compound from the culture
medium allows a reinduction of Pax9 and presumably other
FGF target genes in ba1 mesenchyme. Upon transplantation
under the kidney capsule, such explants develop into
normal-looking teeth. These results exclude any toxic ef-
fects of Su5402 on the mandibular tissue and clearly show
that the loss of expression of Pax9 and other genes in
SU5402-treated explants is not caused by cell death. Fur-
thermore, these results also reveal a surprising robustness
of odontogenic tissue during early development. Appar-
ently, blocking FGF signaling during the time when speci-
fication of the tooth mesenchyme is thought to occur
(between E10.5 and E11.5) does not result in a respecifica-
tion of the odontogenic mesenchyme toward a different
developmental fate but rather seems to induce a pause in
the developmental program.
Like Pax9, the transcription factors Lhx6, Lhx7, and
Barx1 are expressed in odontogenic mesenchyme. Lhx6 and
© 2001 Elsevier Science. ALhx7 expression is detected throughout the mesenchyme
underlying the Fgf8-positive ectoderm (Grigoriou et al.,
1998). In contrast, Barx1 is only expressed in the prospec-
tive molar region due to inhibition by BMP4 produced in
the distal ba1 ectoderm. Barx1 was suggested to specify
molar fate because a block of BMP signaling in the distal
mandibular arch resulted in ectopic Barx1 expression in the
incisor mesenchyme and a fate switch from incisor to molar
development (Tucker et al., 1998b). Expression of all three
genes was shown to be dependent on ectodermal signals at
E10.5 and was induced in response to recombinant FGF
protein. Our results demonstrate that FGF signaling is not
only sufficient but also necessary for their expression at
E10.5.
In contrast, expression of the bicoid-type homeobox gene
Pitx1 in mandibular explants was unaffected by the block of
FGF signaling. Pitx1 is expressed in both mandibular ecto-
derm and mesenchyme (St. Amand et al., 2000). St. Amand
et al. (2000) have reported that FGF signaling is sufficient to
stimulate Pitx1 expression in ba1 mesenchyme. Our results
demonstrate that FGF signaling is not required for Pitx1
expression in the mandibular arch between E9.5 and E10.5,
leaving open a possible requirement for FGF signaling at a
still earlier stage.
We also examined the effect of blocking FGF signaling on
the expression of Msx1 and Msx2. Both genes have been
shown to be targets of BMP signaling during early odonto-
genesis (Vainio et al., 1993). After E11.5, Msx1 expression
was also stimulated by the application of recombinant
FGF4 and FGF9 protein (Kettunen and Thesleff, 1998). As
expected, expression of neither gene was altered in E10.5
explants treated with Su5402. This clearly shows that FGF
signaling is not necessary for the expression of these genes
and furthermore supports the idea that Su5402 specifically
blocks FGF signaling and does not cause unspecific effects
on genes not controlled by FGF signaling.
Specification of Tooth Mesenchyme Involves at
Least Two FGF-Dependent Pathways
Tissue recombination experiments have revealed that
tooth development is initiated by signals from the oral
ectoderm which induce genes required for tooth formation
in the underlying mesenchyme (Jernvall and Thesleff, 2000;
Mina and Kollar, 1987). By E12, the tooth mesenchyme
becomes specified and in recombination experiments can
then instruct heterologous epithelia to form tooth-specific
structures. This transition requires that expression of genes
essential for tooth development in the dental mesenchyme
becomes independent of epithelial signals by E12, even if it
was initially induced by epithelial signals. FGF8 is one of
the epithelial signals involved in the initiation of odonto-
genesis. As expected for the FGF inducible genes Pax9,
Lhx6, Lhx7, and Barx1, all become independent of FGF
signaling before E12. The exact timing when these genes
acquire independence of FGF signaling, however, differs
(summarized in Fig. 7). Our results clearly show that
ll rights reserved.
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557FGF Signaling during Early Tooth Developmentmaintenance of Pax9 and Lhx7 expression still requires FGF
signaling at E10.75 and is maintained in the absence of it
only at E11.0. In contrast, expression of Lhx6 and Barx1
already becomes independent of FGF signaling at E10.75.
Expression of Barx1 and Lhx6 therefore seems not to be
sufficient for the expression of Pax9 and Lhx7 in prospec-
tive tooth mesenchyme. This observation strongly suggests
that specification of the tooth mesenchyme involves the
activation of at least two FGF-dependent pathways that act
in parallel and become independent of FGF signaling at
different time points.
Regulation of Dan Expression in Dental
Mesenchyme
During the initiation stage of tooth development, FGF
and BMP, produced in partially overlapping regions, inter-
act to establish spatially restricted gene expression patterns
in ba1 mesenchymeme (Neubuser et al., 1997; Tucker et
al., 1998b). Dan, the founding member of the Dan family of
TGFb antagonists, is widely expressed in the mesenchyme
underlying the oral ectoderm (Stanley et al., 1998). DAN
has been shown to bind to BMP2 in vitro and with higher
affinity to GDF5 in assays using the Xenopus system
(Dionne et al., 2001; Hsu et al., 1998). Based on its expres-
sion pattern, DAN could contribute to restricting the ef-
fects of BMP2 and BMP4 during the initiation of tooth
development. Our results demonstrate that Dan expression
in ba1 mesenchyme is under the control of ectodermal
signals and that FGF protein is sufficient to maintain Dan
expression, albeit only in a narrow stripe in the medial
region of ba1. FGF signaling, however, is not necessary for
Dan expression. This clearly demonstrates that ectodermal
signals other than FGF must be involved in regulating Dan
expression in vivo. Candidates for such signals include
members of the WNT family, e.g., Wnt10b, which is widely
expressed in ba1 ectoderm (Dassule and McMahon, 1998;
Sarkar and Sharpe, 1999), whereas members of the BMP
family are unlikely to be involved since BMP2-producing
FIG. 7. Summary of the requirement of FGF signaling for the ex
signaling is not required for the expression of Msx1, Msx2, and Pitx
requires FGF signaling until E10.75, whereas Lhx7 and Pax9 expres
FGF signaling is required.cells did not stimulate Dan expression in our experiments.
© 2001 Elsevier Science. AFGF Signaling and Patterning of the Dental
Ectoderm
During embryogenesis, signals produced by a tissue often
not only influence the surrounding tissues but also have
effects on the signal-producing tissue itself (Kawakami et
al., 2001; Kengaku et al., 1998; Sakar et al., 2000). Whether
FGF8 produced in the oral ectoderm has any function in the
regulation of gene expression in the ectoderm itself or
whether it acts only on the underlying mesenchyme re-
mained to be examined. Kettunen et al. (1998) have shown
that, during the initiation stage of tooth development, only
FGFR1 IIIC and FGFR2 IIIB are expressed at significant
levels in Ba1 mesenchyme and ectoderm, respectively.
Since FGF8 and FGF9 had been reported to bind to FGFR1
IIIC but not to FGFR2 IIIb in cell culture assays (MacArthur
et al., 1995; Sato et al., 1993), they suggested that FGF8 and
FGF9 act only on the underlying mesenchyme. Analysis of
the expression of Fgf8, Bmp4, Shh, and Pitx2, four genes
essential for tooth development, in the ectoderm of ex-
plants treated with Su5402 supports this idea. FGF signal-
ing is not essential for the expression of any of these genes
in the oral epithelium at E10.5. Between E10 and E11, FGF
signaling therefore seems to be primarily involved in pat-
terning of the mandibular mesenchyme and the specifica-
tion of the odontogenic mesenchyme.
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